Detalles de la búsqueda
1.
Netrin-1 blockade inhibits tumour growth and EMT features in endometrial cancer.
Nature
; 620(7973): 409-416, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37532934
2.
A multicentric, single arm, open-label, phase I/II study evaluating PSMA targeted radionuclide therapy in adult patients with metastatic clear cell renal cancer (PRadR).
BMC Cancer
; 24(1): 163, 2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38302933
3.
The French multicentric molecular analysis platforms and personalized medicine trials MOST, MOST Plus and MEGAMOST.
Acta Oncol
; 63: 411-417, 2024 May 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38807312
4.
Association between progression-free survival and overall survival in women receiving first-line treatment for metastatic breast cancer: evidence from the ESME real-world database.
BMC Med
; 21(1): 87, 2023 03 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36882736
5.
Cutting Edge: mTORC1 Inhibition in Metastatic Breast Cancer Patients Negatively Affects Peripheral NK Cell Maturation and Number.
J Immunol
; 206(10): 2265-2270, 2021 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33931486
6.
Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer.
N Engl J Med
; 381(25): 2416-2428, 2019 12 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-31851799
7.
Low level of Fibrillarin, a ribosome biogenesis factor, is a new independent marker of poor outcome in breast cancer.
BMC Cancer
; 22(1): 526, 2022 May 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35545761
8.
CaboPoint: a phase II study of cabozantinib as second-line treatment in patients with metastatic renal cell carcinoma.
Future Oncol
; 18(8): 915-926, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34911359
9.
Impact of early palliative care on additional line of chemotherapy in metastatic breast cancer patients: results from the randomized study OSS.
Support Care Cancer
; 31(1): 82, 2022 Dec 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-36574052
10.
Second primary cancers: a retrospective analysis of real world data using the enhanced medical research engine ConSoRe in a French comprehensive cancer center.
Int J Clin Oncol
; 26(10): 1793-1804, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34091824
11.
Design and methods of a national, multicenter, randomized and controlled trial to assess the efficacy of a physical activity program to improve health-related quality of life and reduce fatigue in women with metastatic breast cancer: ABLE02 trial.
BMC Cancer
; 20(1): 622, 2020 Jul 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32620149
12.
Cost-effectiveness of an exercise and nutritional intervention versus usual nutritional care during adjuvant treatment for localized breast cancer: the PASAPAS randomized controlled trial.
Support Care Cancer
; 28(6): 2829-2842, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-31729566
13.
Oral etoposide in heavily pre-treated metastatic breast cancer: results from the ESME cohort and comparison with other chemotherapy regimens.
Breast Cancer Res Treat
; 173(2): 397-406, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30357526
14.
A 96-hour continuous wound infiltration with ropivacaine reduces analgesic consumption after liver resection: A randomized, double-blind, controlled trial.
J Surg Oncol
; 119(1): 47-55, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30481374
15.
Does a homeopathic medicine reduce hot flushes induced by adjuvant endocrine therapy in localized breast cancer patients? A multicenter randomized placebo-controlled phase III trial.
Support Care Cancer
; 27(5): 1879-1889, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30194492
16.
Feasibility of an exercise and nutritional intervention for weight management during adjuvant treatment for localized breast cancer: the PASAPAS randomized controlled trial.
Support Care Cancer
; 27(9): 3449-3461, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-30680617
17.
Nilotinib in locally advanced pigmented villonodular synovitis: a multicentre, open-label, single-arm, phase 2 trial.
Lancet Oncol
; 19(5): 639-648, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29571946
18.
PARP Inhibitors in Ovarian Cancer. Reply.
N Engl J Med
; 382(16): 1574-1575, 2020 04 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-32294365
19.
A first-in-human study investigating biodistribution, safety and recommended dose of a new radiolabeled MAb targeting FZD10 in metastatic synovial sarcoma patients.
BMC Cancer
; 18(1): 646, 2018 Jun 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29884132
20.
HEPATOFLUO: A prospective monocentric study assessing the benefits of indocyanine green (ICG) fluorescence for hepatic surgery.
J Surg Oncol
; 117(5): 922-927, 2018 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-29473963